| 英文别名 |
2-(6-(((6-Fluoroquinolin-2-yl)methyl)amino)-3-azabicyclo[3.1.0]hexan-3-yl)-n-hydroxypyrimidine-5-carboxamide;2-[6-[(6-fluoroquinolin-2-yl)methylamino]-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine-5-carboxamide;CHR-3996;CHR 3996;YTL7A418KQ;Nanatinostat (USAN);Nanatinostat [USAN];CHR3996;GTPL8391;BDBM50347385;WHO 10911;DB15419;SB16879;compound 21r [PMID 21080647];D11442;Q27075994;2-((1alpha,5alpha,6alpha)-6-(((6-Fluoro-2-quinolinyl)methyl)amino)-3-azabicyclo(3.1.0)hex-3-yl)-N-hydroxy-5-pyrimidinecarboxamide;2-[(1R,5S)-6-[(6-fluoroquinolin-2-yl)methylamino]-3-azabicyclo[3.1.0]hexan-;Hdac inhibitor CHR-3996;Nanatinostat;2-[(1S,5R)-6-[(6-fluoroquinolin-2-yl)methylamino]-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine-5-carboxamide;CHEMBL1801250;DA-51875;2-[(1R,5S,6R)-6-{[(6-fluoroquinolin-2-yl)methyl]amino}-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine-5-carboxamide;2-[(1R,5S,6S)-6-{[(6-Fluoroquinolin-2-yl)methyl]amino}-3-azabicyclo[3.1.0]hex-3-yl]-N-hydroxypyrimidine-5-carboxamide;VRX-3996;HY-13432;SCHEMBL22712415;5-PYRIMIDINECARBOXAMIDE, 2-((1.ALPHA.,5.ALPHA.,6.ALPHA.)-6-(((6-FLUORO-2-QUINOLINYL)METHYL)AMINO)-3-AZABICYCLO(3.1.0)HEX-3-YL)-N-HYDROXY-;MS-26622;1256448-47-1;SCHEMBL22712412;AKOS040742271;CS-0006885;2-((1.ALPHA.,5.ALPHA.,6.ALPHA.)-6-(((6-FLUORO-2-QUINOLINYL)METHYL)AMINO)-3-AZABICYCLO(3.1.0)HEX-3-YL)-N-HYDROXY-5-PYRIMIDINECARBOXAMIDE;SCHEMBL22712419;NANATINOSTAT [INN];UNII-YTL7A418KQ;NANATINOSTAT [WHO-DD];5-Pyrimidinecarboxamide, 2-((1alpha,5alpha,6alpha)-6-(((6-fluoro-2-quinolinyl)methyl)amino)-3-azabicyclo(3.1.0)hex-3-yl)-N-hydroxy- |
在线客服
专业包装 品类齐全
厂家直发 快捷到货
品牌正品 质量保证
自助下单 尝选无忧
%3dNC%3dN3)C(C3%3dCC%3dC(OC4%3dCC%3dCC%3dC4)C%3dC3)%3dN2)CCC1)C%3dCCN1CCN(CCNC(CCC2%5bN-%5d3C(C%3dC4N(%5bB%2b3%5d3(%5bF-%5d)%5bF-%5d)%3dC(C)C%3dC4C)%3dCC%3d2)%3dO)CC1)
